International Journal of Molecular Medical Science, 2024, Vol.14, No.1, 8-15 http://medscipublisher.com/index.php/ijmms 15 References Belete T.M., 2021, The Current Status of Gene Therapy for the Treatment of Cancer, Biologics: Targets and Therapy ,15: 67-77. https://doi.org/10.2147/BTT.S302095 PMid:33776419 PMCid:PMC7987258 Cao J.X., Wang Y.L., and Wang Z.X., 2020, Advances in precise regulation of CRISPR/Cas9 gene editing technology, Yichuan (Hereditas), 42(12): 1168-1177. Chen X., Chen L., and Li D.L., 2019, Research progress of gene therapy in clinical application, Shengwu Gongcheng Xuebao (Chinese Journal of Biotechnology), 35(12): 2295-2307. Godbout K., and Tremblay J.P., 2023, Prime editing for human gene therapy: where are we now? Cells, 12(4), 536. https://doi.org/10.3390/cells12040536 PMid:36831203 PMCid:PMC9954691 Wang C.P., 2018, Clinical ethics of human embryo gene editing mediated by CRISPR/Cas9 technology, Ziran Bianzhengfa Tongxun (Journal of Dialectics of Nature), 40(11), 105-112. Wang H.Y., Yang X.F., Hu C.F., and Li F.R., CRISPR/Cas9 gene editing in diabetes cell therapy: recent advances, Shengming Kexue (Chinese Bulletin of Life Sciences), 31(7): 723-730. Xu Y. Y., 2020, Current status and challenges of gene therapy products, Zhonguo Shengwu Gongcheng Zazhi (China Biotechnology), 40(12): 95-103. Yu D.H., Cao H., and Wang X.R., 2021, Advances and applications of organoids: a review, Shengwu Gongcheng Xuebao (Chinese Journal of Biotechnology), 37(11): 3961-3974. Zhang B.H., 2020, CRISPR/Cas gene therapy, Journal of Cellular Physiology, 236(4): 2459-2481. https://doi.org/10.1002/jcp.30064 PMid:32959897 Zhu P.Q., Jiang W.D., and Zhou N., 2019, CRISPR/ Cas9 system and its application in medical research, Zhonguo Bijiao Yixue Zazhi (Chinese Journal Of Comparative Medicine), 29(2): 116-123.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==